Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2,3-dichlorobenzoyl)-4-((5-fluoro-6-((5-methyl-1h-pyrazol-3-yl)amino)pyridin-2-yl)methyl)piperidine-4-carboxylic Acid
2. Tas-119
1. Tas-119
2. 1453099-83-6
3. Tas 119 [who-dd]
4. 6a57j83j27
5. 4-piperidinecarboxylic Acid, 1-(2,3-dichlorobenzoyl)-4-((5-fluoro-6-((5-methyl-1h-pyrazol-3-yl)amino)-2-pyridinyl)methyl)-
6. 1-(2,3-dichlorobenzoyl)-4-((5-fluoro-6-((5-methyl-1h-pyrazol-3-yl)amino)pyridin-2-yl)methyl)piperidine-4-carboxylic Acid
7. Tas119
8. Chembl3692206
9. Schembl16341234
10. Unii-6a57j83j27
11. Gtpl12070
12. Vic1911
13. Ex-a5696
14. Vic 1911
15. Example 1 [us10092556b2]
16. Hy-137377
17. Cs-0138153
18. A936878
| Molecular Weight | 506.4 g/mol |
|---|---|
| Molecular Formula | C23H22Cl2FN5O3 |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 111 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 741 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
A VIC-1911 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of VIC-1911, including repackagers and relabelers. The FDA regulates VIC-1911 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. VIC-1911 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A VIC-1911 supplier is an individual or a company that provides VIC-1911 active pharmaceutical ingredient (API) or VIC-1911 finished formulations upon request. The VIC-1911 suppliers may include VIC-1911 API manufacturers, exporters, distributors and traders.
VIC-1911 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of VIC-1911 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right VIC-1911 GMP manufacturer or VIC-1911 GMP API supplier for your needs.
A VIC-1911 CoA (Certificate of Analysis) is a formal document that attests to VIC-1911's compliance with VIC-1911 specifications and serves as a tool for batch-level quality control.
VIC-1911 CoA mostly includes findings from lab analyses of a specific batch. For each VIC-1911 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
VIC-1911 may be tested according to a variety of international standards, such as European Pharmacopoeia (VIC-1911 EP), VIC-1911 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (VIC-1911 USP).
LOOKING FOR A SUPPLIER?
